ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,200 | -88.0% | 800 | -87.3% | 0.00% | – |
| Q2 2023 | $10,001 | -6.9% | 6,290 | -58.0% | 0.00% | – |
| Q1 2023 | $10,740 | +2214.7% | 14,979 | +1772.4% | 0.00% | – |
| Q4 2022 | $464 | -53.6% | 800 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 800 | -23.8% | 0.00% | – |
| Q1 2022 | $1,000 | -100.0% | 1,050 | -100.0% | 0.00% | -100.0% |
| Q4 2021 | $3,754,000 | -45.0% | 2,132,641 | -32.2% | 0.00% | -50.0% |
| Q3 2021 | $6,822,000 | -37.6% | 3,143,669 | +0.7% | 0.00% | -50.0% |
| Q2 2021 | $10,925,000 | -66.4% | 3,121,326 | -5.3% | 0.00% | -63.6% |
| Q1 2021 | $32,502,000 | +7.7% | 3,296,389 | +18.4% | 0.01% | +10.0% |
| Q4 2020 | $30,187,000 | +221.6% | 2,784,862 | +205.6% | 0.01% | +150.0% |
| Q3 2020 | $9,387,000 | -73.0% | 911,412 | -45.2% | 0.00% | -73.3% |
| Q2 2020 | $34,709,000 | +43.6% | 1,662,350 | -32.8% | 0.02% | +36.4% |
| Q1 2020 | $24,170,000 | -25.4% | 2,473,928 | -12.1% | 0.01% | 0.0% |
| Q4 2019 | $32,417,000 | +160.8% | 2,813,931 | +23.4% | 0.01% | +120.0% |
| Q3 2019 | $12,430,000 | -66.7% | 2,280,667 | -27.3% | 0.01% | -64.3% |
| Q2 2019 | $37,317,000 | +245.0% | 3,138,539 | +52.1% | 0.01% | +250.0% |
| Q1 2019 | $10,815,000 | +294.1% | 2,064,004 | +137.0% | 0.00% | +300.0% |
| Q4 2018 | $2,744,000 | +2186.7% | 870,888 | +4293.5% | 0.00% | – |
| Q3 2018 | $120,000 | +62.2% | 19,822 | +41.9% | 0.00% | – |
| Q2 2018 | $74,000 | +393.3% | 13,973 | +443.1% | 0.00% | – |
| Q1 2018 | $15,000 | +150.0% | 2,573 | +43.9% | 0.00% | – |
| Q3 2017 | $6,000 | 0.0% | 1,788 | -26.3% | 0.00% | – |
| Q2 2017 | $6,000 | +50.0% | 2,425 | +50.8% | 0.00% | – |
| Q1 2017 | $4,000 | -75.0% | 1,608 | -70.7% | 0.00% | – |
| Q4 2016 | $16,000 | -5.9% | 5,487 | +36.7% | 0.00% | – |
| Q3 2016 | $17,000 | +466.7% | 4,014 | +264.9% | 0.00% | – |
| Q2 2016 | $3,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |